Zogenix Announces Results From Global Pivotal Phase 3 Trial of FINTEPLA For The Treatment Of Lennox-Gastaut Syndrome Met Primary Endpoint; Co. Also Reported FINTEPLA Also Demonstrated Statistically Significant Improvement on Multiple Secondary Endpoints